Analysis of Various Treatment Methods of Granulomatous Lobular Mastitis
Recruiting
Observational Study
Granulomatous Mastitis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 15 – 65
- Sex
- Female
- Study type
- Observational
- Participants needed
- 350 (estimated)
- Sponsor
- First Affiliated Hospital of Harbin Medical University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Granulomatous lobular mastitis (GLM) is a rare benign breast disease that is difficult to distinguish from breast cancer based on clinical and imaging findings, and there is currently no standard treatment. This study aims to analyze the clinical characteristics and demographic data of GLM patients and to compare the overall effectiveness of three treatment methods: surgery alone, triple anti-tube…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* non-lactating and aged 15-65 years
* histopathological confirmation of GLM
* normal liver and kidney function
Exclusion Criteria:
* lactating and pregnant women
* allergies to rifampin, isoniazid, or ethambutol
* concurrent malignant breast tumors
* severe underlying disease…
Contacts